XML 14 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Shareholders Equity - USD ($)
Series A Preferred Stock
Common Stock
Additional Paid-In Capital
Discount To Par Value
Comprehensive Income
Accumulated Deficit
Minority Shareholders Interest
Total
Beginning Balance, Shares at Dec. 31, 2019 4,000,000 2,027,085,665            
Beginning Balance, Value at Dec. 31, 2019 $ 40,000 $ 20,270,857 $ 23,344,885 $ (17,728,779) $ 806,719 $ (42,459,781) $ 700,000 $ (15,026,099)
Warrants Exercised, Shares   59,999,999            
Warrants Exercised, Value   $ 600,000   (510,000)       90,000
Fair value of warrants issued to convertible debt holders     1,207,214         1,207,214
Conversion of convertible notes, Shares   175,763,466            
Conversion of convertible notes, Amount   $ 1,757,635 97,000 (582,850)       1,271,785
Foreign currency translation         29,606     29,606
Net loss           (2,368,156)   (2,368,156)
Dividends accrued           (30,847)   (30,847)
Ending Balance, Shares at Mar. 31, 2020 4,000,000 2,262,849,130            
Ending Balance, Value at Mar. 31, 2020 $ 40,000 $ 22,628,492 24,649,099 (18,821,629) 836,325 (44,858,784) $ 700,000 (14,826,497)
Beginning Balance, Shares at Dec. 31, 2020   155,483,897            
Beginning Balance, Value at Dec. 31, 2020   $ 1,554,838 23,188,527   727,976 (45,491,885)   (20,020,544)
Warrants Exercised, Shares   103,000,000            
Warrants Exercised, Value   $ 1,030,000   (937,048)       92,952
Shares issued for commitment fees, Shares   2,700,000            
Shares issued for commitment fees, Value   $ 27,000 138,780         165,780
Conversion of convertible notes, Shares   1,316,679,078            
Conversion of convertible notes, Amount   $ 13,166,792   (12,635,787)       531,005
Foreign currency translation         (185,813)     (185,813)
Net loss           (10,338,286)   (10,338,286)
Ending Balance, Shares at Mar. 31, 2021   1,577,862,975            
Ending Balance, Value at Mar. 31, 2021   $ 15,778,630 $ 23,327,307 $ 13,572,835 $ 542,163 $ 55,830,171   $ (29,754,906)